¿ËÈÕ£¬£¬£¬ngµç×ÓÓÎϷҽѧԺ¹ùµÂÒø½ÌÊÚÍŶÓÔÚ¹ú¼Ê×ÅÃûÆÚ¿¯Cell ResearchÔÓÖ¾ÔÚÏß½ÒÏþÁËÌâΪ¡°A novel selective autophagy receptor, CCDC50, delivers K63 polyubiquitination-activated RIG-I/MDA5 for degradation during viral infection¡±µÄÑо¿ÂÛÎÄ(Hou et al., 2020)¡£¡£¡£¸ÃÑо¿·¢Ã÷RNA²¡¶¾Ñ¬È¾ËÞÖ÷ϸ°û¿ÉÓÕµ¼±í´ïÒ»ÖÖÐÂÐÍ×ÔÊÉÊÜÌåCCDC50£¬£¬£¬¸Ã×ÔÊÉÊÜÌåͨ¹ýʶ±ðK63ÐÍ·ºËØ»¯ÐÞÊεÄRNA²¡¶¾Ä£Ê½Ê¶±ðÊÜÌåRIG-I/MDA5£¨RLR£©²¢½éµ¼ºóÕßµÄ×ÔÊÉ;¾¶ÒÀÀµµÄ½µ½â£¬£¬£¬´Ó¶øÒÖÖƲ¡¶¾Ñ¬È¾ÓÕµ¼µÄIÐÍ×ÌÈÅËصı¬·¢£¬£¬£¬×ÊÖú»úÌå»Ö¸´µ½¾²Ï¢×´Ì¬£¬£¬£¬×èֹ̫¹ýÃâÒß·´Ó³Ôì³ÉµÄ×éÖ¯ËðÉ˺Í×ÔÉíÑ×Ö¢¡£¡£¡£ngµç×ÓÓÎÏ·²©Ê¿ºóºîÅÎÅÎΪÂÛÎĵÚÒ»×÷Õߣ¬£¬£¬¹ùµÂÒø½ÌÊÚΪͨѶ×÷Õߣ¬£¬£¬ngµç×ÓÓÎϷҽѧԺ¡¢¡¢¡¢Á¥ÊôµÚÆßҽԺΪµÚÒ»×÷Õßµ¥Î»¡£¡£¡£

×ÔÈ»ÃâÒßÊÇÒ»ÖÖ·ÇÌØÒìÐÔµÄËÞÖ÷·´¿¹²¡Ô­Î¢ÉúÎïÈëÇÖµÄÃâÒß·´Ó³,ËüÆձ鱣´æÓÚ»úÌåµÄ¾ø´ó²¿·Öϸ°û£¬£¬£¬±»ÒÔΪÊÇ»úÌå·´¿¹²¡Ô­ÌåѬȾµÄµÚÒ»µÀ·ÀÏß¡£¡£¡£Ëæ׎ü¼¸Ê®ÄêµÄÑо¿£¬£¬£¬ÈËÃǶÔ×ÔÈ»ÃâÒßϵͳÓú·¢Ïàʶ£¬£¬£¬ÒѾ­·¢Ã÷²¢Åжϳö×ÔÈ»ÃâÒß·´Ó³µÄÒªº¦µ÷¿ØÒò×ÓºÍÐźÅתµ¼Òò×Ó£¬£¬£¬È»¶øijЩÖ÷Òªµ÷¿ØÒò×ӵĽṹºÍ¹¦Ð§»úÖÆÒÀÈ»²»ÇåÎú£¬£¬£¬ÇÒÕâЩµ÷¿ØÒò×ÓµÄÐÄÀíºÍ²¡Àí×÷ÓÃÉÐÓдýÓÚÑо¿¡£¡£¡£¹ùµÂÒø½ÌÊÚ¿ÎÌâ×éʹÓÃCRISPR/Cas9µÚ¶þ´úÎÄ¿âÔÚÃâÒßϸ°ûÖоÙÐÐÁËÈ«»ùÒò×éˮƽµÄ´ó¹æÄ£ÎÞÎó²îɸѡ£¬£¬£¬·¢Ã÷ÁËһϵÁмÓÈë×ÔÈ»ÃâÒß·´Ó³µ÷¿ØµÄÐÂÐÍ»ùÒò¡£¡£¡£½øÒ»²½µÄÑéÖ¤Àú³ÌÖз¢Ã÷CCDC50ÂÑ°×ÔÚRNA²¡¶¾Ñ¬È¾Ï±í´ïÁ¿ÏÔÖøÔöÌíÇÒÆä±í´ïģʽºÍRLRµÄ±í´ïģʽһÖ£¬£¬£¬ÌáÐÑ×ÅCCDC50¿ÉÄܼÓÈëµ÷¿ØRLR½éµ¼µÄÐźÅͨ·»îÐÔ¡£¡£¡£ÎªÁ˽øÒ»²½ÑéÖ¤¸ÃÊÓ²ìЧ¹û£¬£¬£¬¸Ã¿ÎÌâ×é¹¹½¨ÁËCCDC50Ìõ¼þȱʧµÄСÊóÄ£×Ó£¬£¬£¬¹¥¶¾ÊµÑéЧ¹û֤ʵȱʧCCDC50ºó£¬£¬£¬²¡¶¾Ñ¬È¾Ìõ¼þÏ£¬£¬£¬IÐÍ×ÌÈÅËرí´ïÉϵ÷£¬£¬£¬ÆäÏÂÓεÄISGs±í´ïˮƽҲËæÖ®Éý¸ß£¬£¬£¬Ð¡Êóɨ³ý²¡¶¾ÄÜÁ¦ÔöÇ¿£¬£¬£¬·Î²¿×éÖ¯ËðÉ˺ÍÑ×ÐÔ½þÈóïÔÌ­£¬£¬£¬ÇÒСÊó´æ»îÂÊÔöÌí£¬£¬£¬´Ó¶ø֤ʵCCDC50ÔÚ»úÌåˮƽ¾ßÓÐÐÄÀíѧ¹¦Ð§¡£¡£¡£

½øÒ»²½µÄ»úÖÆ̽ÌÖÖУ¬£¬£¬¸Ã¿ÎÌâ×é·¢Ã÷CCDC50ÌØÒìÐÔʶ±ðK63·ºËØ»¯ÐÞÊεÄRLR£¬£¬£¬²¢Ôö½ø¼¤»îµÄRLRµÄ×ÔÊÉ;¾¶ÒÀÀµµÄ½µ½â£¬£¬£¬´Ë»úÖƲî±ðÓÚÒÔÍùÏàʶ½Ï¶àµÄK48·ºËØ»¯ÒÀÀµµÄ½µ½âµ÷¿Ø¡£¡£¡£¸ÃÀú³ÌµÄ±¬·¢²¢²»ÒÀÀµÓÚ³£¼ûµÄ×ÔÊÉÊÜÌåp62£¬£¬£¬ Òòp62ȱʧºó£¬£¬£¬CCDC50ÒÀÈ»¿ÉÒÔÔö½øRLRµÄ½µ½â£¬£¬£¬µ«CCDC50¿ÉÓëp62Эͬ×÷Óᣡ£¡£ÁõÓ­·¼½ÌÊÚÍŶÓÆÊÎöÁËCCDC50·Ö×ÓLIR½á¹¹ÓòºÍLC3¸´ºÏÌåµÄ¾§Ìå½á¹¹£¬£¬£¬½á¹¹ÆÊÎö֤ʵCCDC50Öб£´æÒ»¶Î·Çµä·¶µÄLIR»ùÐò£¬£¬£¬¸Ã»ùÐò¿ÉÒÔÁ¬ÏµÎ»ÓÚLC3µÄLDSÁ¬ÏµÎ»µã£¬£¬£¬½«K63·ºËØ»¯ÐÞÊεÄRLRÀ­½ø×ÔÊÉСÌå¡£¡£¡£ÓÐȤµÄÊÇ£¬£¬£¬½ôÁÚLIR»ùÐò£¬£¬£¬CCDC50ÓÐÒ»¶ÎMIU»ùÐò£¬£¬£¬¸Ã»ùÐò¿É³ÆΪ·´ÏòUIM»ùÐò£¬£¬£¬ÌåÍâÉú»¯ÊµÑé֤ʵCCDC50-MIU¿ÉÒÔÁ¬ÏµÔÚLC3µÄUDSλµã£¬£¬£¬½ø¶ø֤ʵCCDC50ÊÇÒ»ÖÖÐÂÐÍ×ÔÊÉ»õÎïÊÜÌ壬£¬£¬¿ÉÒÔÒÔÁ½¶Î²î±ðµÄÊèË®»ùÐòÁ¬ÏµÔÚLC3µÄ²î±ðλµã¡£¡£¡£ÕâÀà×ÔÊÉ»õÎïÊÜÌåÊÇÊ×´ÎÔÚÉúÎïÌåÄÚ±»·¢Ã÷£¬£¬£¬ÆäÊÂÇé»úÖƼûÏÂͼ¡£¡£¡£

CCDC50µ÷¿Øϸ°û×ÔÊÉÓ뿹²¡¶¾ÏÈÌìÃâÒßÓ¦´ð½»Ö¯·´Ó³µÄʾÒâͼ

ϸ°û×ÔÊɺͿ¹²¡¶¾×ÔÈ»ÃâÒßÔÚ¼¹×µ¶¯ÎïµÄ½ø»¯ÖУ¬£¬£¬¹¦Ð§¶¼¼«ÎªÊؾÉ£¬£¬£¬Á½¸öÐźÅͨ·µÄ½»Ö¯·´Ó³Ò²Öð²½»ñµÃÕ¹ÏÖ¡£¡£¡£¹ùµÂÒø½ÌÊÚ¿ÎÌâ×é·¢Ã÷£¬£¬£¬ÃæÁÙ²¡¶¾ÇÖȾ£¬£¬£¬»úÌ屬·¢IÐÍ×ÌÈÅËصÄͬʱÓÕµ¼±í´ïÁËÒ»¸öÓÕµ¼ÐÍ×ÔÊÉÊÜÌ壬£¬£¬Ê¹µÃ»úÌå¼È¿ÉÒÔ˲ʱ±¬·¢Ç¿Ê¢µÄÃâÒß·´Ó³ÒÔɨ³ý²¡¶¾£¬£¬£¬ÓÖ¿Éͨ¹ýʵʱµÄ¸ºµ÷¿ØѸËÙ»Ö¸´µ½ÎÈ̬£¬£¬£¬×èÖ¹×ÔÉíÑ×Ö¢ÐÔËðÉË¡£¡£¡£¾ÝϤ£¬£¬£¬¸Ã¿ÎÌâ×黹·¢Ã÷CCDC50µÄ±í´ïˮƽºÍһЩ×ÔÉíÃâÒß²¡µÄ¼²²¡Ï£Íû¾ßÓÐÒ»¶¨µÄÏà¹ØÐÔ£¬£¬£¬¸Ã²¿·ÖÑо¿»¹ÔÚ¾ÙÐÐÖС£¡£¡£¶øCCDC50ÄÜ·ñ×÷Ϊ°Ðµã£¬£¬£¬ÓÃÓÚ¿¹²¡¶¾ºÍ×ÔÉíÃâÒß²¡µÄ·ÀÖÎÉÐÓдýÓÚ½øÒ»²½µÄÑо¿¡£¡£¡£

¸ÃÊÂÇéÊܵ½¹ú¼Ò×ÔÈ»¿Æѧ»ù½ð¡¢¡¢¡¢¹ã¶«Ê¡¡°Öé½­È˲ÅÍýÏ롱ºÍÉîÛÚÊп×ȸÍŶӵÈÏîÄ¿µÄÖ§³Ö¡£¡£¡£

ÂÛÎÄÁ´½Ó£º£ºhttps://doi.org/10.1038/s41422-020-0362-1